“and telling that story to the right parties, to bring in sufficient funding (estimated at US$50 million) for us to execute through commercialization in mid-2020.”
Nice article. It says all we need to do is list on Nasdaq and we get instant analyst coverage and institutional funds. One thing we know about institutional investors is that they always pay the same price as retail.
David McNally: “there appears to be an appetite particularly in the area of surgical robotics for investment in what could be the next great robotic technology.”